Grossman Jerrold B purchased $51K of ADMA
Grossman Jerrold B purchased 6,400 shares of ADMA BIOLOGICS, INC. (ADMA) at $7.91 on 2026-05-27.
How this was made
The 30-second read
Why it matters
The disclosure updates insider ownership and can slightly influence sentiment, but it does not provide new guidance, trial results, contracts, or regulatory actions.
Market read
Traders may note the insider buy as a small sentiment input, but it is unlikely to drive a durable repricing without accompanying fundamental news.
What to watch
The article notes no pre-arranged 10b5-1 plan, but it still provides no context on motivation, timing constraints, or whether other insiders are buying/selling.
Background
The article is a SEC Form 4 insider transaction disclosure for ADMA BIOLOGICS, Inc.
Ticker impact
ADMA BIOLOGICS director Grossman Jerrold B bought 6,400 shares at $7.91 in a Form 4 filed May 28, 2026.
Likely limited near-term impact; any effect is sentiment-driven and typically fades unless followed by additional disclosures.
The filing is a primary-source Form 4 and is company-specific, but it does not include new operational, financial, or regulatory information beyond the transaction details.
Market effects
No clear sector read-through from a single director open-market purchase.
None indicated.
None indicated.
Counterpoint
Insider buys can be routine, tax-related, or part of personal liquidity planning, so the signal may be weak.
Key entities
- issuerADMA BIOLOGICS, INC.
Company whose director insider purchase is disclosed on Form 4.
- insiderGrossman Jerrold B
Director who purchased 6,400 shares at $7.91 on May 27, 2026.
